Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

HLA Haplo-Identical Peripheral Blood Stem Cell Transplantation Using High-Dose Cyclophosphamide Post-Transplantation For Poor Prognosis Or Refractory Acute Leukemia and Myelodysplastic Syndrome: A Prospective Pilot Study At a Single Center

Hirohisa Nakamae, MD, PhD, Hideo Koh, M.D., Ph.D., Mitsutaka Nishimoto, M.D., Ph.D., Yasuhiro Nakashima, M.D., Ph.D., Satoru Nanno, M.D., Takuro Yoshimura, M.D., Ph.D., Shiro Koh, M.D., Hiroshi Okamura, M.D., Jyoji Nagasaki, M.D., Takahiko Nakane, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Asao Hirose, M.D., Ph.D., Masayuki Hino, MD, PhD

Blood (2013) 122 (21): 3404.

https://doi.org/10.1182/blood.V122.21.3404.3404

Published: 2013

Journal Articles

Diagnostic Value Of Serum Level Of Soluble CD14-Subtype In Febrile Neutropenia In Patients With Hematologic Disorders

Hideo Koh, M.D., Ph.D., Hirohisa Nakamae, MD, PhD, Mizuki Aimoto, M.D., Takako Katayama, Asao Hirose, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Masayuki Hino, MD, PhD

Blood (2013) 122 (21): 4718.

https://doi.org/10.1182/blood.V122.21.4718.4718

Published: 2013

Journal Articles

Risk Factors Affecting Cardiac Left Ventricular Systolic and Diastolic Function and Hypertrophy in the Chronic Phase Post-Allogeneic Hematopietic Cell Transplantation

Mitsutaka Nishimoto, M.D., Hirohisa Nakamae, MD, PhD, Takahiko Nakane, M.D., Ph.D., Hideo Koh, M.D., Ph.D, Yoshiki Hayashi, M.D., Mika Nakamae, M.D., Ph.D, Masahiro Yoshida, M.D., Masato Bingo, M.D., Hiroshi Okamura, M.D., Mizuki Aimoto, M.D., Masahiro Manabe, M.D., Takuro Yoshimura, M.D., Akiko Inaba, M.D., Satoshi Nanno, M.D., Asao Hirose, M.D., Ph.D., Kiyoyuki Hagihara, M.D., Ph.D, Yoshitaka Nakao, M.D., Ph.D, Yoshiki Terada, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2011) 118 (21): 2000.

https://doi.org/10.1182/blood.V118.21.2000.2000

Published: 2011

Journal Articles

Immunoprofile of Patients with Chronic Myeloid Leukemia Treated with Imatinib, Nilotinib or Dasatinib,

Yoshiki Hayashi, M.D., Hirohisa Nakamae, MD, PhD, Takako Katayama, Takahiko Nakane, M.D., Ph.D., Hideo Koh, M.D., Ph.D, Mitsutaka Nishimoto, M.D., Mika Nakamae, M.D., Ph.D, Masahiro Yoshida, M.D., Masato Bingo, M.D., Hiroshi Okamura, M.D., Mizuki Aimoto, M.D., Masahiro Manabe, M.D., Takuro Yoshimura, M.D., Akiko Inaba, M.D., Satoshi Nanno, M.D., Kiyoyuki Hagihara, M.D., Ph.D, Yoshitaka Nakao, M.D., Ph.D, Yoshiki Terada, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2011) 118 (21): 3764.

https://doi.org/10.1182/blood.V118.21.3764.3764

Published: 2011

Journal Articles

Factors That Contribute to Long-Term Survival In Patients with Leukemia Not In Remission at Allogeneic Hematopoietic Cell Transplantation

Blood (2010) 116 (21): 3551.

https://doi.org/10.1182/blood.V116.21.3551.3551

Published: 2010

Journal Articles

Possible Involvement of γδ-T Cells in the Development of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Ki-Ryang Koh, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Hongzhang Li, M.D., Hideo Koh, M.D., Takahiko Nakane, M.D., Yasunobu Takeoka, M.D., Asao Hirose, M.D., Ph.D., Kiyoyuki Hagihara, M.D., Ph.D., Erina Sakamoto, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Yoshiki Terada, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2007) 110 (11): 1971.

https://doi.org/10.1182/blood.V110.11.1971.1971

Published: 2007

Journal Articles

The Impact of Relative Dose Intensity (RDI) of CHOP on Outcome of Diffuse Large B-Cell Lymphoma: Results of a Single Center Study.

Yoshiki Terada, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Takahiko Nakane, M.D., Hideo Koh, M.D., Yasunobu Takeoka, M.D., Ran Moriguchi, M.D., Mizuki Aimoto, M.D., Yuki Akazawa, M.D., Eri Wada, M.D., Hiroshi Kanashima, M.D., Ph.D., Erina Sakamoto, M.D., Ph.D., Ki-Ryang Koh, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Yoshitaka Nakao, M.D., Ph.D., Hirofumi Teshima, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2007) 110 (11): 4456.

https://doi.org/10.1182/blood.V110.11.4456.4456

Published: 2007

Journal Articles

Non-TBI, Non-ATG Containing Fludarabine-Based Regimen for Unrelated Allogeneic Reduced Intensity Transplantation.

Hirohisa Nakamae, MD, PhD, Takahiko Nakane, M.D., Hideo Koh, M.D., Yasunobu Takaoka, M.D.,Ph.D., Erina Sakamoto, M.D.,Ph.D., Hiroshi Kanashima, M.D.,Ph.D., Hiroyoshi Ichihara, M.D., Mika Nakamae, M.D.,Ph.D., Ki-Ryang Koh, M.D.,Ph.D., Takahisa Yamane, M.D.,Ph.D., Masayuki Hino, M.D.,Ph.D.

Blood (2006) 108 (11): 5382.

https://doi.org/10.1182/blood.V108.11.5382.5382

Published: 2006

Journal Articles

Decreased Serum Levels of Surfactant Protein D (SP-D) Prior Transplant Is Associated with the Development of Bronchiolitis Obliterans (BO) and Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Hematopoietic Stem Cell Transplantation.

Takahiko Nakane, MD, Hirohisa Nakamae, M.D.,Ph.D., Hiroshi Kamoi, M.D.,Ph.D., Hideo Koh, M.D., Yasunobu Takeoka, M.D., Erina Sakamoto, M.D.,Ph.D., Hiroshi Kanashima, M.D.,Ph.D., Hiroyoshi Ichihara, M.D., Mika Nakamae, M.D.,Ph.D., Ki-Ryang Koh, M.D.,Ph.D., Takahisa Yamane, M.D.,Ph.D., Masayuki Hino, M.D.,Ph.D.

Blood (2006) 108 (11): 2915.

https://doi.org/10.1182/blood.V108.11.2915.2915

Published: 2006

Journal Articles

Preferential Th2 Polarization at the Onset of Thrombotic Microangiopathy (TMA): Immunological Comparison of TMA Versus Acute GVHD in Terms of Peripheral T Cell Subsets, Dendritic Cell Subsets and Cytokine Profiles.

Ki-Ryang Koh, MD, PhD, Hirohisa Nakamae, M.D., Ph. D., Kensuke Ohta, M.D., Ph. D., Hideo Koh, M.D., Takahiko Nakane, M.D., Mika Nakamae, M.D., Ph. D., Hiroshi Kanashima, M.D., Ph. D., Kiyoyuki Hagihara, M.D., Ph. D., Erina Sakamoto, M.D., Ph. D., Yoshiki Terada, M.D., Ph. D., Yasunobu Takeoka, M.D., Asao Hirose, M.D., Ph. D., Takahisa Yamane, M.D., Ph. D., Masayuki Hino, M.D., Ph.D

Blood (2006) 108 (11): 2885.

https://doi.org/10.1182/blood.V108.11.2885.2885

Published: 2006

NARROW

HLA Haplo-Identical Peripheral Blood Stem Cell Transplantation Using High-Dose Cyclophosphamide Post-Transplantation For Poor Prognosis Or Refractory Acute Leukemia and Myelodysplastic Syndrome: A Prospective Pilot Study At a Single Center

Diagnostic Value Of Serum Level Of Soluble CD14-Subtype In Febrile Neutropenia In Patients With Hematologic Disorders

Risk Factors Affecting Cardiac Left Ventricular Systolic and Diastolic Function and Hypertrophy in the Chronic Phase Post-Allogeneic Hematopietic Cell Transplantation

Immunoprofile of Patients with Chronic Myeloid Leukemia Treated with Imatinib, Nilotinib or Dasatinib,

Factors That Contribute to Long-Term Survival In Patients with Leukemia Not In Remission at Allogeneic Hematopoietic Cell Transplantation

Possible Involvement of γδ-T Cells in the Development of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

The Impact of Relative Dose Intensity (RDI) of CHOP on Outcome of Diffuse Large B-Cell Lymphoma: Results of a Single Center Study.

Non-TBI, Non-ATG Containing Fludarabine-Based Regimen for Unrelated Allogeneic Reduced Intensity Transplantation.

Decreased Serum Levels of Surfactant Protein D (SP-D) Prior Transplant Is Associated with the Development of Bronchiolitis Obliterans (BO) and Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Hematopoietic Stem Cell Transplantation.

Preferential Th2 Polarization at the Onset of Thrombotic Microangiopathy (TMA): Immunological Comparison of TMA Versus Acute GVHD in Terms of Peripheral T Cell Subsets, Dendritic Cell Subsets and Cytokine Profiles.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only